awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33628420-9833B4AB-2859-42D2-8FA4-E3638239A315
Q33628420-9833B4AB-2859-42D2-8FA4-E3638239A315
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33628420-9833B4AB-2859-42D2-8FA4-E3638239A315
Early hepatitis B viral DNA clearance predicts treatment response at week 96
P2860
Q33628420-9833B4AB-2859-42D2-8FA4-E3638239A315
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33628420-9833B4AB-2859-42D2-8FA4-E3638239A315
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0e4cc004da37a7f4c636badb443e3c53ea533859
P2860
2-Year GLOBE trial results: telbivudine Is superior to lamivudine in patients with chronic hepatitis B.